The Super Bowl aired a Hims & Hers commercial that is receiving backlash for its non-FDA approved weight loss drug. This drug ...

Hims & Hers Health's (NYSE: HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

Yeezy isn’t the only company being called out for its “bait-and-switch” Super Bowl commercial, a Californian company called ...

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the FDA.

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without ...

Pfizer clinches the top spot in the competitive 2025 Super Bowl ad race, promising groundbreaking visibility during the big ...

The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss ...

U.K.-based ad agency DAIVID said Pfizer had a strong, positive message with its ad and scored high with intense positive emotions. The commercial was also a top performer with spikes in positive ...

Oneview Healthcare today introduced Ovie, an innovative new GenAI product that provides personalized, real-time support for patients and families throughout their hospital stay.